609 Followers on Owler
OverviewCompetitorsAcquisitionsFundingNews & Insights

CytomX Competitors or Alternatives

CytomX's top competitors include ADC Therapeutics, ADC Bio and Meditope.

Unlock 12 more competitors →

RANK

COMPANY

CEO

CEO RATING

EMPLOYEES

FUNDING

REVENUE

  • FUNDING

    REVENUE

  • EMPLOYEES

    FUNDING

  • REVENUE

  • CEO RATING

  • EMPLOYEES

  • FUNDING

  • REVENUE

CytomX's company profile

Sean A. McCarthy

Chairman & CEO

88/100
170
$320.6M
$138.1M
  • $320.6M
    $138.1M
  • 170
    $320.6M
  • $138.1M
  • 88/100
  • 170
  • $320.6M
  • $138.1M
View ProfileView
1
CytomX's Competitor - ADC Therapeutics logo

Ameet Mallik

President & CEO

86/100
265
$1.4B
$70.8M
  • $1.4B
    $70.8M
  • 265
    $1.4B
  • $70.8M
  • 86/100
  • 265
  • $1.4B
  • $70.8M
View ProfileView
2
CytomX's Competitor - ADC Bio logo

Alan Raymond

Chairman

87/100
25 - 100
$5.4M
$100K - 5M
  • $5.4M
    $100K - 5M
  • 25 - 100
    $5.4M
  • $100K - 5M
  • 87/100
  • 25 - 100
  • $5.4M
  • $100K - 5M
View ProfileView
3
CytomX's Competitor - Meditope logo

Stephanie Hsieh

President & CEO

82/100
25 - 100
$7.3M
$5M - 25M
  • $7.3M
    $5M - 25M
  • 25 - 100
    $7.3M
  • $5M - 25M
  • 82/100
  • 25 - 100
  • $7.3M
  • $5M - 25M
View ProfileView
4
CytomX's Competitor - Igenica logo

Robert Schreiber

Co-Founder

78/100
25 - 100
$58.1M
$100K - 5M
  • $58.1M
    $100K - 5M
  • 25 - 100
    $58.1M
  • $100K - 5M
  • 78/100
  • 25 - 100
  • $58.1M
  • $100K - 5M
View ProfileView
5
CytomX's Competitor - Cara Therapeutics logo

Christopher Posner

President & CEO

86/100
10
$587.3M
$7.1M
  • $587.3M
    $7.1M
  • 10
    $587.3M
  • $7.1M
  • 86/100
  • 10
  • $587.3M
  • $7.1M
View ProfileView
CytomX's top 15 competitors are ADC Therapeutics, ADC Bio, Meditope, ImmunGene, Igenica, Cara Therapeutics, BeiGene, BioAtla, Rigel Pharmaceuticals, Principia Biopharma, Inc., Immunophotonics, Paragon Gene, Cytovance, OBT and Genentech. Together they have raised over 7.5B between their estimated 25.8K employees. CytomX has 170 employees and is ranked 6th among it's top 10 competitors. The top 10 competitors average 1,621.

CytomX VS ADC Therapeutics

ADC Therapeutics is one of CytomX's top competitors. ADC Therapeutics was founded in 2011, and its headquarters is in Epalinges, Vaud. Like CytomX, ADC Therapeutics also works within the Biotechnology sector. ADC Therapeutics has 95 more employees than CytomX.

CytomX VS ADC Bio

ADC Bio is CytomX's #2 rival. ADC Bio was founded in 2010 in Chester, England. ADC Bio operates in the Biotechnology industry. ADC Bio generates $134.1M less revenue than CytomX.

CytomX VS Meditope

Meditope is a top competitor of CytomX. Meditope is a Private company that was founded in Pasadena, California in 2011. Meditope is in the Biotechnology field. Meditope has 120 fewer employees vs. CytomX.

Looking for similar companies to CytomX?

Similar Companies

Companies in South San Francisco with revenue in $100-500M range

See 20 companies 
Biotechnology companies in South San Francisco

See 150 companies 
Companies in South San Francisco with employees in 100-250 range

See 124 companies 
Pharmaceuticals & Biotechnology companies in South San Francisco

See 173 companies 
Biotechnology companies with revenue in $100-500M range

See 234 companies 
Pharmaceuticals & Biotechnology companies with revenue in $100-500M range

See 569 companies 
Companies in San Francisco Bay Area with revenue in $100-500M range

See 860 companies 
Biotechnology companies with employees in 100-250 range

See 1,110 companies 
Biotechnology companies in San Francisco Bay Area

See 1,319 companies 

Advanced Search

PRO

Discover new companies using five search parameters, including sector, location, public/private company status, employee count, and annual revenue.

Discover new companies using five search parameters.

Trending News for CytomX and CytomX's Competitors

April 23, 2025Benzinga
SAN DIEGO, April 23, 2025 (GLOBE NEWSWIRE) -- BioAtla, Inc. (NASDAQ:BCAB), a global clinical-stage biotechnology company focused on the development of ...
April 24, 2025Seeking Alpha
April 24, 2025Benzinga
NEW YORK , April 24, 2025 /PRNewswire/ -- The Gross Law Firm issues the following notice to shareholders of Cerevel Therapeutics Holdings, Inc. ABBV . ...
April 24, 2025Indian Pharma Post
Multiple studies show the combination potential of vedotin antibody-drug conjugates (ADCs) with pembrolizumab, including the first Phase 1 data in thor...
April 24, 2025PMLiVE
The collaboration will leverage Repertoire's immune mapping DECODE platform...
April 24, 2025FinanzNachrichten
WASHINGTON (dpa-AFX) - AbbVie (ABBV) Thursday said it has submitted Biologics License Application (BLA) to the U.S. Food and Drug Administration (FDA) ...
April 23, 2025Endpoints News
Every few years, Repertoire Immune Medicines makes a major announcement in April. And this year is no different. The Flagship Pioneering-incubated star...
April 24, 202524/7 Wall St.
Pfizer (NYSE:PFE) is a global pharmaceutical giant that has long been a cornerstone of medical innovation and today boasts a $128 billion market cap. R...
April 23, 2025centralcharts
Pfizer Inc. (NYSE: PFE) today announced that its board of directors declared a $0.43 second-quarter 2025 dividend on the company's common stock, payabl...
April 24, 2025StreetInsider
Multi-year global collaboration will utilize Guardant liquid biopsy portfolio in research and clinical applications and evaluate utility of ctDNA for m...

Frequently Asked Questions about CytomX

  1. Who are CytomX's top competitors?

    CytomX's top 3 competitors are ADC Therapeutics, ADC Bio, Meditope.

  2. Who is similar to CytomX?

    ADC Therapeutics is the most similar to CytomX. ADC Bio and Meditope are also similar to CytomX.

  1. Are CytomX and ADC Therapeutics competitors?

    Yes, ADC Therapeutics is one of CytomX’s top competitors.